Sales Director – CNS Business Unit

About the role

Pharmazac is seeking an experienced, commercially driven Sales Director to lead its Central Nervous System (CNS) Business Unit. The role carries full responsibility for sales performance, market share growth and commercial execution of the CNS portfolio across Greece.

Key responsibilities

• Define and execute the CNS BU sales strategy aligned with overall business objectives.
• Drive sales growth, profitability and market share for the CNS portfolio.
• Lead, motivate and develop a high‑performing CNS sales organization.
• Develop annual business plans, forecasts, budgets and sales initiatives.
• Monitor market trends, customer needs and competitive activity to identify growth opportunities.
• Build strong relationships with neurologists, psychiatrists, KOLs, hospitals and other healthcare stakeholders.
• Collaborate with Medical, Market Access, Marketing, Finance, Regulatory and other functions.
• Support product launches, lifecycle management and represent Pharmazac at scientific congresses and industry events.

Required profile

• Degree in Life Sciences, Pharmacy, Medicine, Business Administration, Sales or related field.
• 10+ years of pharmaceutical sales/commercial experience, including significant CNS exposure.
• Proven track record of sales growth, market development and achievement of business targets.
• Strong knowledge of the CNS therapeutic area, especially Neurology and Psychiatry.
• Established relationships with neurologists, psychiatrists, KOLs and key healthcare stakeholders.
• Experience in product launches and portfolio management; generic and innovative pharma experience is an asset.
• Fluent English, valid driver’s licence and availability for regional travel.

What we offer

• Competitive salary.
• Company car.
• Mobile phone.
• Hospital medical insurance.
• Comprehensive training and professional development opportunities.
• Collaborative, science‑driven and growth‑oriented work environment.
• Opportunity to work for a strong and respected brand in the Greek pharmaceutical market.